Dr. Martens plc (LON:DOCS – Get Free Report) insider Giles Wilson purchased 269 shares of Dr. Martens stock in a transaction that occurred on Tuesday, March 11th. The stock was acquired at an average cost of GBX 56 ($0.73) per share, with a total value of £150.64 ($195.03).
Giles Wilson also recently made the following trade(s):
- On Tuesday, February 11th, Giles Wilson purchased 207 shares of Dr. Martens stock. The shares were bought at an average cost of GBX 73 ($0.95) per share, with a total value of £151.11 ($195.64).
- On Monday, January 13th, Giles Wilson bought 222 shares of Dr. Martens stock. The stock was bought at an average price of GBX 68 ($0.88) per share, for a total transaction of £150.96 ($195.44).
Dr. Martens Stock Up 1.3 %
LON:DOCS traded up GBX 0.70 ($0.01) during mid-day trading on Wednesday, reaching GBX 54.85 ($0.71). The stock had a trading volume of 1,714,085 shares, compared to its average volume of 3,107,159. The company has a market capitalization of £532.46 million, a price-to-earnings ratio of 7.78, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The stock’s 50 day simple moving average is GBX 68.93 and its two-hundred day simple moving average is GBX 64.88. The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13. Dr. Martens plc has a 1-year low of GBX 49.32 ($0.64) and a 1-year high of GBX 99.40 ($1.29).
Dr. Martens Cuts Dividend
About Dr. Martens
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Featured Articles
- Five stocks we like better than Dr. Martens
- Quiet Period Expirations Explained
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- What is a buyback in stocks? A comprehensive guide for investors
- Why Energy Transfer Belongs on Your Watchlist
- What Investors Need to Know About Upcoming IPOs
- Why Wayfair Stock May Be a Hidden Gem for Value Investors
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.